Labcorp director granted 773 RSUs

Labcorp Holdings Inc. director Kerrii B. Anderson received an equity award of 773 Restricted Stock Units on February 10, 2026.

Rhea-AI Filing Summary

Labcorp Holdings Inc. director Kerrii B. Anderson received an equity award of 773 Restricted Stock Units on February 10, 2026. The award was reported as an acquisition of derivative securities at a price of $0 per unit under a standard grant or award transaction code.

Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. common stock. These units vest fully on February 10, 2027. Following this grant, Anderson beneficially owns a total of 1,670 Restricted Stock Units, all held as direct ownership.

Insider Trade Summary

Grant/Award: 773 shares

Grant/Award 1 txn

Insider ANDERSON KERRII B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	773	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 1,670 contracts (Direct)

Footnotes (3)

1. F1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
2. F2. The Restricted Stock Units vest fully on February 10, 2027.
3. F3. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Labcorp (LH) report for Kerrii B. Anderson?

Labcorp reported that director Kerrii B. Anderson received a grant of 773 Restricted Stock Units on February 10, 2026. The award was recorded at a price of $0 per unit as a standard equity grant for board service.

How many Labcorp (LH) Restricted Stock Units does Kerrii B. Anderson now hold?

After the February 10, 2026 grant, Kerrii B. Anderson beneficially owns 1,670 Restricted Stock Units. This figure reflects the aggregate number of RSUs held directly, as disclosed in the Form 4 footnotes and post-transaction ownership column.

When do Kerrii B. Anderson’s new Labcorp (LH) Restricted Stock Units vest?

The newly granted 773 Restricted Stock Units for Kerrii B. Anderson vest fully on February 10, 2027. Vesting means the units become earned at that date, representing the right to receive Labcorp common shares, subject to the plan’s terms.

What does each Labcorp (LH) Restricted Stock Unit represent in this Form 4?

Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. common stock. This means that, upon vesting and settlement under plan terms, each RSU can convert into one share for the reporting person.

Was Kerrii B. Anderson’s Labcorp (LH) RSU transaction a purchase or a grant?

The transaction was a grant or award acquisition, not an open-market purchase. It is coded as an acquisition under a grant, award, or other similar transaction, with a transaction price of $0 per unit, typical of equity compensation.

Is Kerrii B. Anderson’s ownership in Labcorp (LH) RSUs direct or indirect?

The Form 4 shows that Kerrii B. Anderson’s 1,670 Restricted Stock Units are held with direct ownership. No nature of indirect beneficial ownership or related entity is indicated in the filing’s ownership-type and footnote disclosures.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/12/2026 - 10:59 AM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ANDERSON KERRII B

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	02/10/2026		A		773		(2)	(2)	Common Stock	773	$0	1,670(3)	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. The Restricted Stock Units vest fully on February 10, 2027.

3. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Kathryn W. Kyle Attorney-in-Fact for Kerrii B. Anderson	02/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.